CHARLES SCHWAB INVESTMENT MANAGEMENT INC - PROTEON THERAPEUTICS INC ownership

PROTEON THERAPEUTICS INC's ticker is PRTO and the CUSIP is 74371L109. A total of 33 filers reported holding PROTEON THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of PROTEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$86,000
-49.7%
10,9980.0%0.00%
Q4 2015$171,000
+11.8%
10,9980.0%0.00%
Q3 2015$153,000
-22.3%
10,9980.0%0.00%
Q2 2015$197,00010,9980.00%
Other shareholders
PROTEON THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Deer VII & Co. Ltd. 315,101$599,00025.51%
Abingworth LLP 2,017,872$3,632,0003.04%
Pharmstandard International S.A. 1,165,344$2,214,0001.91%
MPM ASSET MANAGEMENT LLC 983,381$1,868,0000.88%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,332,599$2,532,0000.10%
Perceptive Advisors 334,116$635,0000.04%
Baker Brothers Advisors 389,394$740,0000.01%
WEDBUSH SECURITIES INC 17,000$32,0000.01%
FINANCIAL COUNSELORS INC 50,000$95,0000.01%
PILLAR PACIFIC CAPITAL MANAGEMENT LLC 11,499$21,0000.00%
View complete list of PROTEON THERAPEUTICS INC shareholders